SUMMARY: The effect of oral administration of a polysaccharide (KGF-C), isolated from the kefir grain, on delayed-type hypersensitivity (DTH) induced by picryl chloride and on the growth of solid tumor was examined in mice. KGF-C caused an increase in DTH response in intact mice and also tumor-bearing mice. The growth of tumor inoculated after the DTH test was markedly inhibited in the groups with high DTH response. A significant correlation between the DTH response and the antitumor activity was observed in intact mice.
We have previously reported that a water-soluble polysaccharide (KGF-C), isolated from the kefir grain, possesses an antitumor activity on the allogeneic solid tumor in mice (Shiomi et al., 1982) . The mechanism of the antitumor activity was considered to be host mediated because of the lack of direct in vitro cytotoxicity of the substance on tumor cells. Since it has widely been accepted that the immune system, especially cell-mediated immunity, plays a protective role in neoplastic disease (Green et al., 1977) , we studied the effect of oral administration of KGF-C on the delayed-type hypersensitivity (DTH) response induced by picryl chloride.
Male ddY mice, 5-8 weeks old, obtained from Funabashi Animal Farms, Funabashi, Chiba, and Shizuoka Agricultural Cooperative Association for Laboratory Animals, Hamamatsu, Shizuoka, were used. Different doses of KGF-C prepared by the method described in the previous paper (Shiomi et al., 1982) were given to mice by gastric intubation or freely in drinking water. The DTH test was carried out by painting the abdominal skin with picryl chloride and then examining the increase in the ear thickness induced by the agent (Natsume and Migita, 1975) . The mice were painted on the shaved abdominal The results of the DTH test showed that a single administration of 5 to 200 mg/kg of KGF-C by gastric intubation on days 1 and 11 increased the response. In all the groups except the 50 mg/kg dosing group, the increase in the ear thickness was significantly larger than that seen in the control group (Table  I ). An increased response was also observed in those given KGF-C freely in drinking water for 24 hr on both days 1 and 11, namely, drinking 0.0015% (equivalent to about 2.5 mg/kg of body weight) or 0.03% (equivalent to about 50 mg/kg of body weight) solution of KGF-C increased significantly the response (Table I ). The results suggest that KGF-C given perorally stimulates the cell- To assess the influence of different administration schedules of KGF-C on the DTH response, KGF-C in drinking water was given freely for one , 3 or 7 days during the periods of day 1-7 and day 11-17 , that is, KGF-C was given on days 1 and 11, on days 1, 4, 7, 11, 14 and 17 or every day from day 1 to 7 and from days 11 to 17. When 0.0015% KGF-C solution was used , the most effective schedule was the last one, on the other hand, when 0.03% KGF-C solution was used, the first administration schedule was the most effective (Table II) . The facts that different responses were seen in the same administration schedule and the same responses were seen in different administration schedules suggest that neither the duration nor the frequency of KGF-C administration but the total dose determines the stimulation of the cell-mediated immune system. The reduced efficacy of KGF-C caused by increasing the frequency of administration suggests that an optimal dose level may exist for the effective stimulation .
Tumor growth was examined from day 23 in the groups receiving a single administration of KGF-C by gastric intubation on days 1 and 11 and given freely 0.03% of KGF-C in drinking water. The tumor weights were significantly lower in the groups given 10 mg/kg or 100 mg/kg KGF-C by a gastric intubation and in the group given freely 0.03% of KGF-C on days 1 and 11 than those of each control group (Table I and II) . These results show that KGF-C exerts antitumor action when given not only after tumor inoculation (Shiomi et al., 1982) but also prior to tumor inoculation. A marked inhibition of tumor growth was observed Since daily administration of 0.1% KGF-C in drinking water to tumorbearing mice decreased the tumor weight as reported previously (Shiomi et al., 1982) , the effect of daily administration of the same concentration of KGF-C on DTH response was examined both in intact mice and in tumor-bearing mice. KGF-C given between day -3 and day 7 raised significantly the response measured on days 7-8 in tumor-bearing mice but not in intact mice (Table III) . KGF-C given between days 11 and 17 lowered the response in intact mice but not in tumor-bearing mice (Table III) . These results suggest that daily administration of such high dose levels as 0.1-0.12% KGF-C in drinking water depresses the cell-mediated immune response in intact mice, but stimulates it in tumor-bearing mice. If the correlation between the DTH response and the antitumor effect of KGF-C is taken into account, the different DTH responses between intact and tumor-bearing mice indicates the possibility that larger doses of KGF-C may be needed for its antitumor action when given after tumor inoculation than when given prior to tumor inoculation. Studies to examine this possibility are now in progress.
